SUMMARY
Introduction
The United Nations Office on Drugs and Crime reports that cocaine use has remained stable during the last three years, with 14 to 21 million estimated users per year worldwide. In particular, cocaine use has remained high in North America (5 million), South America (4.5 million), Africa (2.8 million), and Western and Central Europe (4 million) 1 . In the last 2016 European Drug Report, it was estimated that around 17 million adults (15-64 years) have used cocaine at least once in their lifetime with some countries (such as Spain and UK) showing a prevalence of use among young adults (15-34 years) that matches or even exceeds rates in the USA 2 .
The most frequently used route of cocaine administration is intranasal inhalation, or "snorting", and thus adverse effects on the nasal tract are very common 3 . Habitual nasal insufflations of cocaine may cause mucosal lesions, and if cocaine use becomes chronic and compulsive, progressive damage of the mucosa and perichondrium leads to ischaemic necrosis of septal cartilage and perforation of the nasal septum 4 . Occasionally, cocaine-induced lesions cause extensive destruction of the osseocartilaginous structures of nose, sinuses and palate that can mimic other diseases such as tumours, infections and immunological disorders. Several problems have been reported in differentiating cocaine-induced midline destructive lesion (CIMDL) from granulomatosis with polyangiitis (GPA) with limited ear-nose-throat involvement (ENT) 5 . An essential element for achieving correct diagnosis is clinical history, although cocaine abusers rarely admit drug dependency. The presence of a positive ANCA test with either proteinase 3 (PR3) or myeloperoxidase (MPO) specificity facilitates differential diagnosis of GPA from CIMDL, although not in all cases. In the present study, we focus on patients with CIMDL and palatal perforation and review the available literature to discuss the utility of this type of midface destructive lesion as a possible clinical marker that might orient differential diagnosis.
Materials and methods
A series of 10 patients with CIMDL and palate perforation evaluated at the Department of Otorhinolaryngology of San Raffaele Hospital between February 2002 and October 2015 was retrospectively reviewed. This retrospective study adhered to ethical standards according to the Declaration of Helsinki. The patients ranged in age from 28 to 60 years; there were 8 males and 2 females. Follow-up lasted from 8 to 86 months. The duration of cocaine abuse was available in 7 patients, ranging from 2 to 30 years, at doses varying from 1 to 10 g/week. Demographics and past medical history were collected at the initial visit. It is important to underline that data concerning duration and daily dose of cocaine abuse are difficult to estimate because of poor collaboration between cocaine abusers and physicians. All patients underwent physical examination at the outpatient clinic of our Institute that included inspection of the face, oral cavity and oropharynx, as well as inspection of the nasal cavities and nasopharynx using 30° rigid telescopes (4 mm in diameter). During endoscopy, biopsies and samples for bacterial and fungal cultures were taken. A total of 8 mucosal biopsy specimens were evaluated. Sections were stained with haematoxylineosin. Orcein staining was used to evaluate elastic fibres, and periodic-acid Schiff and Ziehl-Nielsen stains were used to identify fungi and mycobacteria, respectively. Ten patients underwent imaging studies; in particular, 7 patients were evaluated using computed tomography (CT) scan, and 3 patients with magnetic resonance imaging (MRI). Sera from 10 patients were tested for ANCA in the laboratory at our Institute. We used indirect immunofluorescence (IIF) microscopy on ethanol-fixed blood donor neutrophils following the standard procedure outlined at the first ANCA workshop 6 . The PubMed database was searched for the available English literature (original papers, case series, and single reports) describing palate perforation in cocaine abusers and in patients suffering from GPA (available at: http://www.actaitalica.it/issues/2017/4-2017/06_TRIMARCHI).
Results
The 10 patients in our study cohort presented with a variable combination of common symptoms, such as epistaxis, oro-nasal regurgitation of solids and liquids, dysphagia, oropharyngeal pain, nasal speech and halitosis. At rhinoscopy, all patients showed necrotising ulcerative lesions, extensive crusting, intranasal destruction of the vomer and perforation of the nasal septum cartilage as well as of the hard and/or soft palate. Eight patients presented destruction of inferior turbinates, 7 of middle turbinates, and one of the right superior turbinate. The medial wall of maxillary sinus was completely reabsorbed in one patient. Oro-nasal communication affected the hard palate in 7 cases, the soft palate in 2 cases, and both the soft and hard palate in one patient. The diameter of the oro-nasal fistula ranged from 1 to 4 cm (Figs. 1, 2) . All patients had positive nasal cultures for Staphylococcus aureus. No positive fungal cultures were observed. Eight biopsies were negative for inflammatory, oncological and immunological diseases (2 patients admitted cocaine use, but did not consent to biopsy). One patient showed strong P-ANCA positivity on immunofluorescence with negative ELISA for both anti-PR3 and anti-MPO antibodies. One patient showed C-ANCA positivity on immunofluorescence with positive ELISA for anti-MPO antibodies. CT scan confirmed the endoscopic features, showing perforation of nasal septum and palate, and destruction of the inferior middle and superior turbinate, whereas MRI revealed areas of abnormal signal in the septal and palate perforation, such as hypointensity of mucosal and submucosal tissue and nonhomogeneous enhancement.
Discussion
CIMDL represents an uncommon complication of habitual intranasal cocaine insufflations 7 . Patients with CIMDL develop extensive destruction of midfacial osseocartilaginous structures, which can resemble different pathological conditions such as oncologic, infectious and immunological diseases 5 . If differential diagnosis between oncologic or infectious disorders and CIMDL is facilitated by histopathological features and microbiological studies, respectively, differentiation between CIMDL and limited ENT GPA may pose several problems. Considering the histological features of CIMDL reported in the literature 5 and in our experience, we frequently found the presence of vascular changes including microabscesses in the venule wall and leukocytoclastic vasculitis, which have been proposed as characteristic features of GPA [8] [9] [10] . Consequently, the histologic changes observed in a large proportion of biopsies from patients with CIMDL might be misinterpreted as "consistent with GPA" 8 . Only extravascular changes consisting in giant cells and microscopic foci of deeply located necrosis may be diagnostic of GPA [5] [6] [7] [8] [9] [10] [11] . However, as described in a previous study 12 , in situ TUNEL assay on biopsy specimens can be useful to demonstrate apoptotic cells because they are highly characteristic features of CIMDL. If histological analysis is non-diagnostic, the next step is ANCA determination, although ANCA test positivity is not always discriminatory between CIMDL and GPA. Anti-neutrophilic cytoplasmic antibodies (ANCAs) directed against proteinase 3 (PR3) or myeloperoxidase (MPO) are sensitive and specific markers for GPA. However, instances of positive ANCA test results have been reported in an unexpectedly large proportion of patients with CIMDL 5 . In order to discriminate between CIMDL and GPA, Wiesner et al. made a detailed analysis of the ANCAs and found a high frequency (84%) of anti-human neutophil elastase (HNE) ANCAs in patients presenting with CIMDL. This finding allowed the authors to conclude that HNE ANCAs are discriminatory, whereas the presence of PR3 ANCAs is not. Consequently, in a clinical setting of necrotising inflammation of the upper respiratory tract, additional testing for HNE ANCAs may be useful in differentiating CIMDL from limited ENT GPA 7 . Unfortunately, this diagnostic method in not commonly available in routine practice. Differential diagnosis is difficult to reach in the case of HNE ANCA negativity, and in this case there are no discriminating elements. To facilitate diagnosis of CIMDL and reduce the rate of misdiagnosis with other pathological conditions, we propose a diagnostic algorithm that takes into account the presence of palate perforation. This can help diagnostic choice when clinical doubt is focused on CIMDL and GPA (Fig. 3) . For this reason, we consider palate perforation to be an additional diagnostic element. In our experience, palate perforation is frequently associated with cocaine abuse 5 , but we have never observed cases of palate perforation in patients with GPA 13 . From a review of the literature, palate perforation has been described in 73 CIMDL patients, while there are only 5 reports of subjects affected by GPA with palate perforation, for which a few comments are warranted. Kasifoglu et al.
14 described the case of a 26-year-old woman admitted with nasal septum and palatal destruction. The authors reported indeterminate cANCA positivity and a histopathological diagnosis of GPA, but these elements were not exhaustive for definitive diagnosis because CIMDL could not be excluded. Moreover, the same authors defined palatal destruction as a rare condition in the course of GPA, citing three papers from literature [15] [16] [17] in which palatal perforation was not mentioned. Molloy et al. 18 did not present a published case, but indirectly describe their personal GPA experience with one case of palatal perforation in a letter. Manganaro et al. 19 imputed their case of soft palatal loss to GPA without ANCA test positivity or biopsy, and therefore with a debatable diagnosis. Aries et al. 20 presented a case of palatal perforation without biopsy because it was refused by the patient: the final diagnosis relied on non-histological criteria for GPA. In contrast, Sciascia et al. 21 presented the case of a 49-yearold woman with perforation of the midline and no other signs of systemic disease. A biopsy revealed a chronic inflammatory process with giant cells, pathognomonic of GPA. Recently, a proportion of idiopathic cases of midline destructive lesion have been attributed to IgG4-related disease (IgG4-RD), a novel systemic fibro-inflammatory condition characterised by tumourous swelling of affected organs and serum IgG4 elevation 22 23 . IgG4-RD was shown to involve midline structures both in the form of mass-forming lesions and nasal or palatal erosions, thereby introducing an additional differential diagnosis to CIMDL. However, in contrast to GPA and CIMDL, the incidence of IgG4-RD is largely unknown and palatal perforation remains an anecdotal observation from a single centre case series that requires further confirmation. In addition, as we recently reported, IgG4-RD might be accurately differentiated from CIMDL thanks to specific histological hallmarks, such as storiform fibrosis, IgG4+ positive plasma cells, and obliterative phlebitis 24 .
In conclusion, our experience and the present review of the literature demonstrate that palatal perforation is strongly suggestive of CIMDL and represents an impor- tant diagnostic element that can enrich diagnostic workup between GPA and CIMDL.
Conclusions
In conclusion, the presence of palate perforation in patients with MDL and negative biopsy and negative ANCA test may represent a clinical marker that strongly favours CIMDL over GPA.
